Boston Scientific gets approvals

Boston Scientific Corp. announced CE Mark approval for its Cognis cardiac resynchronization therapy defibrillator and Teligen implantable cardioverter defibrillator.

According to the Natick-based medical device company, these devices represent entirely new platforms to treat heart failure and sudden cardiac death and are the result of a multi-year research and development effort to provide physicians enhanced clinical options for their patients.
(By Chris Reidy, Globe staff)

•  Previous Entry
• Next Entry